[1] Everest P, Ketley J, Hardy S, et al. Evaluation of salmonella typhimurium mutants in a model of experimental gastroenteritis[J]. Infect Immun, 1999, 67(6): 2 815-2 821.[2] Hur J, Lee J H. Immune responses to new vaccine candidates constructed by a live attenuated salmonella typhimurium delivery system expressing escherichia coli f4, f5, f6, f41 and intimin adhesin antigens in a murine model[J]. J Vet Med Sci, 2011, 73(10): 1 265-1 273. [3] Xin W, Li Y, Mo H, et al. Pspa family fusion proteins delivered by attenuated salmonella enterica serovar typhimurium extend and enhance protection against streptococcus pneumoniae[J]. Infect Immun, 2009, 77(10): 4 518-4 528.[4] Yang X L, Liu W C, Yang W W, et al. Oral immunization of mice with vaccine of attenuated salmonella typhimurium expressing helicobacter pylori urease b subunit[J]. Biomed Environ Sci, 2005, 18(6): 411-418.[5] Rahman M M, Uyangaa E, Han Y W, et al. Oral administration of live attenuated salmonella enterica serovar typhimurium expressing chicken interferon-alpha alleviates clinical signs caused by respiratory infection with avian influenza virus h9n2[J]. Vet Microbiol, 2011, 154(1-2): 140-151.[6] Cheng Ming(程明), He Jin-sheng(何金生), Fu Yuan-hui(付远辉), et al. Antibody responses induced by mucosal DNA vaccine encoding the codon-optimized F protein of human respiratory syncytial virus (RSV) delivered with attenuated salmonella typhimurium(以减毒鼠伤寒沙门菌为载体的人呼吸道合胞病毒F 蛋白DNA 疫苗滴鼻免疫抗体分析)[J]. ActaMicrobiologica Sinica(微生物学报), 2011, 51(7): 965-971.[7] Chen G, Dai Y, Chen J, et al. Oral delivery of the sj23lhd-gst antigen by salmonella typhimurium type iii secretion system protects against schistosoma japonicum infection in mice[J]. PLoS Negl Trop Dis, 2011, 5(9): e1313.[8] Yang Y, Zhang Z, Yang J, et al. Oral vaccination with ts87 DNA vaccine delivered by attenuated salmonella typhimurium elicits a protective immune response against trichinella spiralis larval challenge[J]. Vaccine, 2010, 28(15): 2 735-2 742.[9] Qu D, Yu H, Wang S, et al. Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated salmonella typhimurium against toxoplasma gondii infection in mice[J]. Vet Parasitol, 2009, 166(3-4): 220-227.[10] Tang H, Wang Y. Metabonomics:A revolution in progress[J]. Prog Biochem Biophys, 2006, 33(5): 401-417.[11] Chen Lu(陈璐), Wang Yu-lan(王玉兰). Metabolite composition of planarian analyzed by nuclear magnetic resonance spectroscopy (涡虫代谢物组成的核磁共振分析)[J]. Chinese J Magn Reson(波谱学杂志) , 2013, 30(4): 516-527.[12] Cevallos-Cevallos J M, Danyluk M D, Reyes-De-Corcuera J I. Gc-ms based metabolomics for rapid simultaneous detection of escherichia coli o157:H7, salmonella typhimurium, salmonella muenchen, and salmonella hartford in ground beef and chicken[J]. J Food Sci, 2011, 76(4): M238-M246.[13] Antunes L C M, Arena E T, Menendez A, et al. Impact of salmonella infection on host hormone metabolism revealed by metabolomics[J]. Infect Immun, 2011, 79(4): 1 759-1 769.[14] Clairmont C, Lee K C, Pike J, et al. Biodistribution and genetic stability of the novel antitumor agent vnp20009, a genetically modified strain of salmonella typhimurium[J]. J Infect Dis, 2000, 181(6): 1 996-2 002.[15] Clairmont C, Bermudes D, Ittensohn M, et al. Genetically modified salmonella typhimurium, vnp20009, a novel anticancer agent: Bio-distribution, genetic stability, selective tumor accumulation, and antitumor efficacy[J]. Cancer Gene Ther, 1999, 6(6): S11-S12.[16] Nicholson J K, Connelly J, Lindon J C, et al. Metabonomics: A platform for studying drug toxicity and gene function[J]. Nat Rev Drug Discov, 2002, 1(2): 153-161.[17] Tian Yuan(田园), Tang Hui-ru(唐惠儒). Identification and structural determination of saccharides in rat feces(大鼠粪样中几种糖类物质的结构确定)[J]. Chinese J Magn Reson(波谱学杂志) , 2012, 29(3): 361-371.[18] Jolliffe I. Principal Component Analysis[M]. Wiley Online Library: 2005.[19] Eriksson L, Trygg J, Wold S. CV-ANOVA for significance testing of pls and opls® models[J]. J Chemometr, 2008, 22(11-12): 594-600.[20] Jiang L, Huang J, Wang Y, et al. Metabonomic analysis reveals the ccl4-induced systems alterations for multiple rat organs[J]. J Proteome Res, 2012, 11(7): 3 848-3 859.[21] Fan T W M, Lane A N. Structure-based profiling of metabolites and isotopomers by NMR[J]. Prog Nucl Mag Res Sp, 2008, 52(2-3): 69-117.[22] Wang Y, Tang H, Holmes E, et al. Biochemical characterization of rat intestine development using high-resolution magic-angle-spinning 1h nmr spectroscopy and multivariate data analysis[J]. J Proteome Res, 2005, 4(4): 1 324-1 329.[23] Marchesi J R, Holmes E, Khan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease[J]. J Proteome Res, 2007, 6(2): 546-551.[24] Johnston S J, Ridge S A, Cassidy J, et al. Regulation of dihydropyrimidine dehydrogenase in colorectal cancer[J]. Clin Cancer Res, 1999, 5(9): 2 566-2 570.[25] Jones B V, Begley M, Hill C, et al. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome[J]. Proc Natl Acad Sci USA, 2008, 105(36): 13 580-13 585.[26] Grubb B R. Avian cecum: Role of glucose and volatile fatty acids in transepithelial ion transport[J]. Am J Physiol-Gastr L, 1991, 260(5): G703-G710.[27] Gill S R, Pop M, DeBoy R T, et al. Metagenomic analysis of the human distal gut microbiome[J]. Science, 2006, 312(5778): |